CardiacWire
JANUARY 24, 2024
CardioSignal has already developed digital biomarkers for AFib and heart failure, while more solutions could be on the way for aortic stenosis, coronary artery disease, and pulmonary artery hypertension.
DAIC
FEBRUARY 27, 2024
The first procedures, performed by leading physicians Saibal Kar , MD, FACC, FSCAI, (Program Director, Cardiovascular Disease Fellowship, Los Robles Health System , California, HCA Healthcare National Physician Director, Interventional Cardiology) and Devi Nair , MD, FACC, FHRS, (Director, Cardiac Electrophysiology Division, St.
Mobi Health News - ECG
SEPTEMBER 17, 2024
The AI lineup currently covers both continuous ECG tracking and AFib detection. Mobihealth News spoke with Yuichi Tamura, CEO of Cardio Intelligence, who discussed more about their latest work in detecting AFib and how they are helping Japan shed light on this silent threat. You are currently developing a new AI to detect AFib.
Cardiomatics
APRIL 5, 2024
Prolonged ambulatory ECG monitoring, commonly referred to as Holter testing, increases the chance of detecting abnormalities responsible for the symptoms of cardiovascular diseases, especially those whose pathognomonic symptoms occur only periodically. AFIB/AFL – atrial fibrillation or atrial flutter episodes.
DAIC
DECEMBER 19, 2023
OSA disproportionately affects the 92 million Americans living with cardiovascular disease (CVD), often goes undiagnosed (1) , and doubles the risk for heart failure and other serious cardiovascular conditions. Western Regional Director of Cardiac Electrophysiology, Northwell Health , NY.
DAIC
FEBRUARY 7, 2024
This new document builds off of the previously published Best Practices for Consumer Cardiovascular Technology Solutions in January 2022. Cardiovascular disease is the leading cause of death globally, taking an estimated 695,000 lives in 2021 in the United States, about 1 in every 5 deaths, according to the CDC.
DAIC
JUNE 19, 2024
While the spotlight in 2023 shone on developments around Generative Artificial Intelligence (AI), away from the limelight a quiet revolution in AI was taking place, which promises to transform the way we diagnose, manage, and treat cardiovascular diseases, the world’s leading cause of death.
Expert insights. Personalized for you.
75 
Let's personalize your content